Gillian Shepherd

1.9k total citations · 1 hit paper
26 papers, 1.4k citations indexed

About

Gillian Shepherd is a scholar working on Pharmacology, Immunology and Surgery. According to data from OpenAlex, Gillian Shepherd has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Immunology and 5 papers in Surgery. Recurrent topics in Gillian Shepherd's work include Pharmacology and Obesity Treatment (6 papers), T-cell and B-cell Immunology (4 papers) and Drug-Induced Adverse Reactions (3 papers). Gillian Shepherd is often cited by papers focused on Pharmacology and Obesity Treatment (6 papers), T-cell and B-cell Immunology (4 papers) and Drug-Induced Adverse Reactions (3 papers). Gillian Shepherd collaborates with scholars based in United States, Australia and United Kingdom. Gillian Shepherd's co-authors include Arya M. Sharma, Walmir Coutinho, Ian D. Caterson, Aldo P. Maggioni, Nick Finer, Christian Torp‐Pedersen, Luc F. Van Gaal, Cheryl Renz, Richard A. Rode and W. P. T. James and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

Gillian Shepherd

26 papers receiving 1.3k citations

Hit Papers

Effect of Sibutramine on Cardiovascular Outcomes in Overw... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Shepherd United States 14 751 443 387 204 146 26 1.4k
Daniel M. Riche United States 20 184 0.2× 127 0.3× 586 1.5× 275 1.3× 135 0.9× 54 1.4k
Dolores Ochoa Spain 25 198 0.3× 176 0.4× 94 0.2× 111 0.5× 49 0.3× 98 1.6k
Graziana Lupattelli Italy 18 89 0.1× 415 0.9× 237 0.6× 375 1.8× 426 2.9× 43 1.4k
Spyridon Papaioannou Greece 12 81 0.1× 201 0.5× 289 0.7× 181 0.9× 222 1.5× 33 1.3k
Marc Paccalin France 25 183 0.2× 561 1.3× 57 0.1× 187 0.9× 428 2.9× 109 1.8k
H. Ditschuneit Germany 24 117 0.2× 231 0.5× 449 1.2× 1.0k 5.1× 237 1.6× 117 1.9k
Norman H. Ertel United States 16 98 0.1× 207 0.5× 459 1.2× 160 0.8× 138 0.9× 34 1.3k
Sotirios Tsalamandris Greece 11 76 0.1× 292 0.7× 280 0.7× 231 1.1× 245 1.7× 43 1.5k
Roberto Fabris Italy 19 110 0.1× 754 1.7× 224 0.6× 289 1.4× 473 3.2× 45 1.6k
George S. Hughes United States 14 173 0.2× 115 0.3× 103 0.3× 81 0.4× 95 0.7× 36 732

Countries citing papers authored by Gillian Shepherd

Since Specialization
Citations

This map shows the geographic impact of Gillian Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Shepherd more than expected).

Fields of papers citing papers by Gillian Shepherd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Shepherd. The network helps show where Gillian Shepherd may publish in the future.

Co-authorship network of co-authors of Gillian Shepherd

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Shepherd. A scholar is included among the top collaborators of Gillian Shepherd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Shepherd. Gillian Shepherd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mercer, Rachel, Gillian Shepherd, Qiang Lu, et al.. (2020). Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion. BMJ Open Respiratory Research. 7(1). e000701–e000701. 11 indexed citations
2.
Larimore, Kevin, Roberto Zori, Gillian Shepherd, et al.. (2019). Depletion of interfering IgG and IgM is critical to determine the role of IgE in pegvaliase-associated hypersensitivity. Journal of Immunological Methods. 468. 20–28. 7 indexed citations
3.
Gupta, Soumi, Cary O. Harding, Gillian Shepherd, et al.. (2018). Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. EBioMedicine. 37. 366–373. 59 indexed citations
4.
Sterling, Timothy R., Ruth N. Moro, Andrey Borisov, et al.. (2015). Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study. Clinical Infectious Diseases. 61(4). 527–535. 80 indexed citations
5.
Shepherd, Gillian. (2013). Ancient Identities. Oxford University Press eBooks. 542–557. 1 indexed citations
6.
James, W. P. T., Ian D. Caterson, Walmir Coutinho, et al.. (2010). Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects. New England Journal of Medicine. 363(10). 905–917. 676 indexed citations breakdown →
7.
Caterson, Ian D., Walmir Coutinho, Nick Finer, et al.. (2009). Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead‐in Period. Obesity. 18(5). 987–994. 14 indexed citations
8.
Shepherd, Gillian, et al.. (2009). Pharmacological Therapies of Obesity: A Review of Current Treatment Options. Biomolecules & Therapeutics. 17(4). 348–352. 1 indexed citations
9.
Maggioni, Aldo P., Ian D. Caterson, Walmir Coutinho, et al.. (2008). Tolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial. Journal of Cardiovascular Pharmacology. 52(5). 393–402. 16 indexed citations
10.
11.
Torp‐Pedersen, Christian, Ian D. Caterson, Walmir Coutinho, et al.. (2007). Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. European Heart Journal. 28(23). 2915–2923. 96 indexed citations
12.
Shepherd, Gillian. (2003). Hypersensitivity Reactions to Chemotherapeutic Drugs. Clinical Reviews in Allergy & Immunology. 24(3). 253–262. 154 indexed citations
13.
Bach, David S., Aila Rissanen, Carl M. Mendel, et al.. (1999). Absence of Cardiac Valve Dysfunction in Obese Patients Treated with Sibutramine. Obesity Research. 7(4). 363–369. 71 indexed citations
14.
Barakat, Richard R., et al.. (1992). Allergy to latex surgical gloves: An unfamiliar cause of intraoperative anaphylaxis. Gynecologic Oncology. 46(3). 381–383. 6 indexed citations
15.
Shepherd, Gillian, et al.. (1990). T Cell Receptor Variable Gene Expression: Analysis in Ragweed-Sensitive Patients during Allergen Exposure. International Archives of Allergy and Immunology. 91(3). 306–310. 2 indexed citations
16.
Chiorazzi, Nicholas, et al.. (1989). Conversion of systemic lupus erythematosus to common variable hypogammaglobulinemia☆. The American Journal of Medicine. 87. 449–456. 1 indexed citations
17.
Chiorazzi, Nicholas, et al.. (1989). Conversion of systemic lupus erythematosus to common variable Hypogammaglobulinemia. The American Journal of Medicine. 87(4). 449–456. 16 indexed citations
19.
Siskind, Gregory W., et al.. (1982). AUTOANTI‐IDIOTYPE ANTIBODY PRODUCTION FOLLOWING ANTIGEN INJECTION AND IMMUNE REGULATION *. Annals of the New York Academy of Sciences. 392(1). 345–349. 2 indexed citations
20.
Shepherd, Gillian. (1977). Two Marriage Forms in the Comoro Islands: An Investigation. Africa. 47(4). 344–359. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026